Exploring Fundamental Mechanisms of Mutagenesis Conferred by the Chemotherapeutic DNA Cross Linking Agent Cisplantin Combining Next Generation Sequencing and Genetic Analysis Towards Selective Cancer Killing

StatusActive
Effective start/end date1/01/1830/06/20

Funding

  • (18-0644): £200,168.00